Eli Lilly (NYSE:LLY) stock in focus as obesity treatment demand lifts guidance

LLY(USD1180.16-2.39%)
12 min read | August 15, 2026 08:32 PM PDT | By
Anmol Khazanchi
Google News:

Southern Copper (NYSE:SCCO) stock in focus after record results and ri

Cleveland-Cliffs (NYSE:CLF) stock in focus as steel prices firm and re

Prologis (NYSE:PLD) lifts full-year core funds view amid logistics mom

Equinix (NASDAQ:EQIX) raises full-year guidance on data-center demand

Make Kalkine Media

My Trusted Source

Highlights

• Eli Lilly drew attention as strong demand for weight-loss and diabetes treatments lifted guidance.
• A European regulator cleared one of its treatments for weight management and diabetes.
• Attention centered on the drugmaker’s momentum in the obesity treatment market.

A Drugmaker Riding Obesity Treatment Demand

Eli Lilly (NYSE:LLY)HealthcareEli Lilly and Company (NYSE:LLY)1180.16
USD-28.8402.385%Last Updated at: 2026-08-14T20:09:00Z
stock drew attention this week as strong demand for the company’s weight-loss and diabetes treatments lifted its guidance, alongside a European regulatory clearance that advanced its lineup, spotlighting the pharmaceutical company’s momentum across the healthcare sector. The company raised its sales guidance after reporting demand for its treatments that outpaced expectations, and a European regulator cleared one of its treatments for both weight management and diabetes, marking a milestone in its expansion abroad.

The developments landed within a healthcare sector where the obesity treatment market has become one of the most prominent themes, drawing intense attention as demand for a new generation of weight-loss treatments has surged. For a company at the forefront of that market, strong demand and an expanding regulatory footprint reinforced its position as one of the standout names in the sector

Understanding the Pharmaceutical Sector

Eli Lilly operates in pharmaceuticals, a corner of healthcare focused on discovering, developing, and marketing medicines. Pharmaceutical companies commit heavily to research, advancing candidates through stages of testing before seeking regulatory approval to bring them to market. Once approved, successful medicines can generate substantial demand, and companies work to expand their reach across markets and indications

The sector has been transformed in recent years by the rise of a new generation of treatments for obesity and diabetes. These medicines, which help regulate appetite and blood sugar, have generated extraordinary demand, reshaping the prospects of the companies that make them. The obesity treatment market in particular has become one of the most closely watched themes in healthcare, as the scale of demand has surpassed expectations and companies have raced to expand supply, pursue new formulations, and secure approvals across markets.

Company Operations and Treatment Lineup

Eli Lilly built a leading position in the obesity and diabetes treatment market, with a lineup of medicines that have generated extraordinary demand. The company’s treatments for diabetes and weight management have become central to its story, driving its growth and lifting it to a scale few pharmaceutical companies have reached. Its operations span research and development, manufacturing, and the commercialization of its medicines across markets

The company has worked to expand its lineup and its reach, pursuing new formulations, including an oral treatment, and seeking approvals across markets. Its research pipeline includes next-generation candidates aimed at extending its position in the obesity treatment market. This focus on the obesity and diabetes market, and on expanding its lineup and reach, has defined the company’s story, and the latest developments reflected the momentum of that effort

What the Latest Developments Conveyed

The developments that drew attention this week centered on strong demand and an expanding regulatory footprint. The company raised its sales guidance after reporting demand for its weight-loss and diabetes treatments that outpaced expectations, a signal of the extraordinary appetite for its medicines. The raised guidance framed the period ahead in stronger terms, reflecting the momentum of the obesity treatment market

A European regulator cleared one of the company’s treatments for both weight management and diabetes, marking the first approval the treatment received in that region and advancing the company’s expansion abroad. The company has also pointed to its pipeline of next-generation candidates, positioning it to extend its position in the market. The combination of strong demand, raised guidance, and an expanding regulatory footprint offered a narrative of a company at the forefront of a powerful theme, drawing attention across the sector.

The Market Environment This Week

The developments arrived within a healthcare sector where the obesity treatment market has become one of the most prominent themes. Demand for the new generation of weight-loss treatments has surged, drawing intense attention to the companies that make them. Within that environment, a company at the forefront of the market reporting strong demand and raising guidance naturally drew attention

The pharmaceutical sector has long been sensitive to the prospects of individual medicines and the markets they serve. The obesity treatment market in particular has commanded attention given the scale of demand. This week’s developments provided a concrete marker of that demand, reinforcing the company’s place at the center of one of the sector’s defining themes, and the company features among the large names that anchor major market gauges

Sector Trends Shaping the Story

Several trends frame the company’s position. The first is the surge in demand for the new generation of obesity and diabetes treatments, which has reshaped the prospects of the companies that make them. The second is the race to expand supply, pursue new formulations, and secure approvals across markets. The third is the pursuit of next-generation candidates aimed at extending positions in the market

Each of these trends touches the company. Its leading lineup gives it direct exposure to the surge in demand, its pursuit of new formulations and approvals reflects the race to expand, and its pipeline of next-generation candidates aligns with the pursuit of extending its position. These alignments help explain why the developments resonated, positioning the company as a leader in one of healthcare’s most prominent themes

Business Positioning Within Healthcare

Eli Lilly occupies a prominent spot in the healthcare landscape. As a leader in the obesity and diabetes treatment market, it holds a central position in one of the sector’s defining themes. The extraordinary demand for its treatments has lifted it to a scale few pharmaceutical companies have reached, and its pipeline positions it to extend that position

This positioning carries both advantages and challenges. The leading lineup gives the company direct exposure to a market of extraordinary demand, while sustaining that position requires expanding supply, pursuing new formulations, securing approvals, and advancing its pipeline against competition. Managing the demands of a rapidly growing market and extending its lineup have been central to the company’s approach, and the latest developments reflected the momentum of that effort

Recent Developments and Operational Focus

The recent period reflected an operational focus on meeting demand, expanding its reach, and advancing its pipeline. The raised guidance pointed to demand that outpaced expectations, while the European clearance advanced the company’s expansion abroad. Its pursuit of new formulations, including an oral treatment, and its pipeline of next-generation candidates reflected its effort to extend its position

The company has emphasized its momentum in the obesity treatment market and its effort to expand its lineup and reach, framing its story around the extraordinary demand for its medicines. This focus on meeting demand and extending its position has become central to how the company presents itself, aligning it with one of the most prominent themes across the healthcare sector

Industry Challenges to Watch

The path carries challenges. Meeting the extraordinary demand for its treatments requires expanding supply, a significant undertaking. Competition in the obesity treatment market is intensifying, as other companies pursue their own treatments and next-generation candidates. Pricing dynamics and access considerations shape the market, and the path for pipeline candidates through testing and approval remains uncertain

The company must manage these challenges while sustaining its momentum and extending its position. The scale of demand brings both promise and the pressure to keep pace with it. These pressures are inherent to a leader in a rapidly growing and increasingly competitive market across the healthcare sector

The Competitive Landscape

The market for obesity and diabetes treatments has drawn a field of major pharmaceutical companies, each racing to develop and supply the new generation of medicines. Competition has intensified as companies pursue their own treatments, new formulations, and next-generation candidates. In this environment, Eli Lilly has leaned on its leading lineup, its scale, and its pipeline to occupy a prominent position

Sustaining that position requires ongoing execution. The company must expand supply to meet demand, secure approvals across markets, and advance its pipeline against intensifying competition. The latest developments underscored its momentum, which helps explain the attention they drew, even as the competitive challenges that define the market persist

Readers following the wider space can trace this story across the broader healthcare sector, where the obesity treatment market, the race to expand supply and reach, and the pursuit of next-generation candidates have become recurring themes shaping how companies position themselves

The Scale of Obesity Treatment Demand

A defining force behind the company’s momentum has been the extraordinary scale of demand for its obesity and diabetes treatments. The new generation of medicines has generated appetite that has surpassed expectations, reshaping the prospects of the companies that make them. This scale of demand has been central to the company’s growth, lifting it to a size few pharmaceutical companies have reached

For the company, this demand represents both a powerful driver and ang supply and managing the demands of a rapidly growing market, while the strength of demand underpins the momentum reflected in its raised guidance. The scale of the obesity treatment market has become the defining feature of the company’s story, and the strong demand reported this week illustrated the extent of that appetite

Expanding Reach Across Markets

The European clearance highlighted the company’s effort to expand its reach across markets. Securing approvals in new regions extends the company’s commercial footprint, exposing its treatments to demand beyond its home market. The clearance for both weight management and diabetes marked a milestone in that expansion, advancing the company’s presence in an important region

This expansion matters because it broadens the sources of demand for the company’s treatments and extends its position in the obesity market internationally. Navigating the regulatory processes of different regions requires effort and expertise, and the European clearance reflected progress in that expansion. This international dimension has become an increasingly relevant part of the company’s story, complementing the strong demand in its home market and reinforcing its momentum across the healthcare sector.

New Formulations and Convenience

An element of the company’s effort to extend its position has been the pursuit of new formulations, including an oral treatment intended to complement its injectable medicines. Different formulations can appeal to different preferences, and an oral option in particular offers convenience that may broaden the appeal of a treatment. Pursuing a range of formulations reflects an effort to reach as many suitable users as possible and to defend a position against competition

For the company, these new formulations represent an avenue to extend the reach of its treatments and reinforce its position in a competitive market. An oral option that offers convenience could complement its injectable medicines, broadening the ways in which its treatments reach users. This pursuit of new formulations has become part of how the company seeks to maintain its momentum, complementing the strong demand for its existing treatments and its expansion across markets within the healthcare sector.

Pipeline and the Next Generation

The company’s pipeline of next-generation candidates highlighted its effort to extend its position over time. Developing new treatments aimed at improving on existing options represents a way to stay ahead in a market where competition is intensifying. The company has pointed to candidates advancing through its pipeline, positioning it to build on its current lineup as the obesity treatment market evolves

This pipeline matters because it shapes the durability of the company’s position in a rapidly evolving market. A company that continues to advance new candidates stands to extend its lead, while one that relies solely on existing treatments risks being overtaken. The company’s emphasis on its pipeline reflected an effort to sustain its momentum over the longer term, reinforcing its position at the forefront of one of healthcare’s most prominent themes

This article is for information only and does not constitute financial advice

Broader Market Relevance

The company’s momentum carries relevance beyond its own shares. As a leader in the obesity treatment market, its demand and guidance offer a read on the strength of one of healthcare’s most prominent themes. Strong demand, raised guidance, and an expanding regulatory footprint reinforce a narrative about the extraordinary appetite for the new generation of treatments, a theme that resonates across the pharmaceutical corner of the sector

That is why developments at a leading drugmaker can inform sentiment across a range of related names. The read-through touches other companies pursuing obesity treatments and the many firms tied to the theme’s prospects. This week’s developments illustrated that dynamic, with the company’s momentum reflecting and reinforcing wider attention to the obesity treatment market

Looking Across the Week

As the week progressed, Eli Lilly stood out as a name where strong demand and an expanding regulatory footprint reinforced one another. The raised guidance spoke to demand that outpaced expectations, the European clearance spoke to expanding reach, and the pipeline spoke to the effort to extend its position, all within a healthcare sector where the obesity treatment market has become a defining theme

Whether the company can sustain its momentum and extend its position amid intensifying competition remains the central question hanging over the name. For now, the developments offered a snapshot of a leading drugmaker riding extraordinary demand while expanding its reach and advancing its pipeline, a story that resonated in a week shaped by the prominence of the obesity treatment market

To keep reading, please log in to your account, create a free account, or simply fill out the form below

`;

$(document).find(“#signup_form button[type=’submit’]”).closest(“button”).before(htmlMsg);

setTimeout(() => {
$(“.errorDiv”).fadeOut(300, function () { $(this).remove(); });
}, 3000);
}

jQuery.validator.addMethod(“validName”, function(value, element) {
value = value.trim();
return this.optional(element) || /^(?=(?:.*[A-Za-z]){2,})[A-Za-z]+(?: [A-Za-z]+)*$/.test(value);
}, “Please enter at least 2 letters (letters and single spaces only).”);

function updateResendOtpTimer() {
if (countdown > 0) {
countdown–;
$(“#timer”).text(countdown + “s”);
} else {
clearInterval(timer);
countdown = 30;
otpSent = false;
$(“#resendOtpText”).hide();
$(“#sendOtpLink”).show();
}
}

function sendOtp() {
const phoneInputVal = $(document).find(“#lead_phone”).val().trim();
const dialCode = iti.getSelectedCountryData().dialCode;
const allowedCountries = [“44”, “61”, “1”, “91”, “64”];

if (!phoneInputVal) return showMessage(“error”, “Please enter a mobile number.”);
if (!iti.isValidNumber()) return showMessage(“error”, “Please enter a valid mobile number.”);
if (!allowedCountries.includes(dialCode)) return showMessage(“error”, “OTP is only available for “+ [“au”,”gb”,”ca”,”nz”,”us”,”in”,”uk”]);

if(!otpSent){
$(document).find(“#lead_otp”).val(“”);
}

const phoneNumber = dialCode + phoneInputVal;
request_id = $(document).find(“#ref_id”).val() || ”;

otpSent = true;
$(document).find(“#sendOtpLink”).hide();
$(document).find(“#resendOtpText”).show();
//$(document).find(“.otp-form-group”).hide();

$.ajax({
url: “https://kalkinemedia.com/a/verification”,
type: ‘POST’,
data: { phone_number: phoneNumber, request_id },
headers: { ‘X-CSRF-TOKEN’: ‘jWzLcq7G6rLJFs8CkQXalU2RktZaisJITmmwKk7q’ },
success: function (response) {
if (response.status === “success”) {
showMessage(“success”, response.message);
//$(document).find(“.otp-form-group”).show();

if ($(document).find(“#ref_id”).length) {
$(document).find(“#ref_id”).val(response.request_id);
} else {
$(”).attr({
type: ‘hidden’,
id: ‘ref_id’,
name: ‘ref_id’,
value: response.request_id
}).appendTo(‘#signup_form’);
}

countdown = 30;
timer = setInterval(updateResendOtpTimer, 1000);
} else {
otpSent = false;
showMessage(“error”, response.message);
$(document).find(“#resendOtpText”).hide();
$(document).find(“#sendOtpLink”).show();
}
},
error: function () {
otpSent = false;
showMessage(“error”, “An error occurred. Please try again.”);
$(document).find(“#resendOtpText”).hide();
$(document).find(“#sendOtpLink”).show();
}
});
}

function verifyOtp() {
$(document).find(“div.otp-form-group div.spinner-border”).removeClass(“d-none”);
// $(document).find(“div.otp-form-group span#verifyOtpLink”).addClass(“d-none”);

$.ajax({
url: “https://kalkinemedia.com/a/verificationChecks”,
type: ‘POST’,
data: {
request_id: $(document).find(“#ref_id”).val(),
code: $(document).find(“#lead_otp”).val()
},
headers: {
‘X-CSRF-TOKEN’: ‘jWzLcq7G6rLJFs8CkQXalU2RktZaisJITmmwKk7q’
},
success: function(response) {
$(document).find(“div.otp-form-group div.spinner-border”).addClass(“d-none”);
if (response.status === “success”) {
otpVerified = true;
showMessage(“success”, response.message);
$(document).find(“#lead_otp”).prop(“disabled”, true);
// $(document).find(“#signup_form button”).removeClass(“d-none”)
setTimeout(() => toggleReadNowButton(), 0);
// if($(“#hotstock_checkbox”).is(“:checked”)){
// $(document).find(“#signup_form button[type=’submit’]”).prop(“disabled”, false);
// }else{
// $(document).find(“#signup_form button[type=’submit’]”).prop(“disabled”, true);
// }

$(document).find(“#sendOtpLink”).addClass(“d-none”);
$(document).find(“#resendOtpText”).hide();
$(document).find(“#verifyOtpLink”).addClass(“d-none”);
$(document).find(“#successBadge”).removeClass(“d-none”);
} else {
otpVerified = false;
showMessage(“error”, response.message);
setTimeout(() => toggleReadNowButton(), 0);
// $(document).find(“#signup_form button[type=’submit’]”).prop(“disabled”, true);
// $(document).find(“#verifyOtpLink”).removeClass(“d-none”);
}
$(document).find(“#lead_otp”).prop(“disabled”, otpVerified);
},
error: function(xhr, status, error) {
$(document).find(“div.otp-form-group div.spinner-border”).addClass(“d-none”);
showMessage(“error”, error.message);
// $(document).find(“#verifyOtpLink”).removeClass(“d-none”);
$(document).find(“#signup_form button[type=’submit’]”).prop(“disabled”, true);
}
});
}

$(document).find(“#sendOtpLink”).on(“click”, sendOtp);

$(document).on(“input”, “#lead_otp”, function () {
const otp = $(this).val();
if (otp.length === 6) {
verifyOtp();
}
});
// $(document).find(“#verifyOtpLink”).on(“click”, verifyOtp);

function toggleSendOtpButton() {
// if (!iti) return;
const name = $(“#lead_name”).val().trim();
const email = $(“#lead_email”).val().trim();
const phone = $(“#lead_phone”).val().trim();
// const checkbox = $(“#hotstock_checkbox”).is(“:checked”);

const isNameValid = name.length >= 2 && /^[a-zA-Zs]+$/.test(name);

// Validate email: basic email format
const isEmailValid = /^[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+.[a-zA-Z]{2,}$/.test(email);

// Validate phone using intlTelInput
const isPhoneValid = iti && iti.isValidNumber();

// Checkbox validation: must be checked
// const isCheckboxChecked = checkbox;

// If all fields are valid, enable the OTP button
if (isNameValid && isEmailValid && isPhoneValid) {
$(document).find(“#sendOtpLink”).css({“opacity”:”1″, “pointer-events”:”auto”});
} else {
$(document).find(“#sendOtpLink”).css({“opacity”:”0.5″, “pointer-events”:”none”});
}

// const formValid = $(“#signup_form”).valid();
//const phoneValid = iti.isValidNumber();
//if (formValid && phoneValid) {
// $(document).find(“#sendOtpLink”).css({“opacity”:”1″,”pointer-events”:”auto”});
//$(document).find(“#sendOtpLink”).show();
//} else {
// $(document).find(“#sendOtpLink”).css({“opacity”:”0.5″,”pointer-events”:”none”});
//$(document).find(“#sendOtpLink”).hide();
// }
}

function toggleReadNowButton(){

const name = $(“#lead_name”).val().trim();
const email = $(“#lead_email”).val().trim();
const phone = $(“#lead_phone”).val().trim();

const isNameValid = name.length >= 2 && /^[a-zA-Zs]+$/.test(name);
const isEmailValid = /^[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+.[a-zA-Z]{2,}$/.test(email);
const isPhoneValid = iti && iti.isValidNumber();

checkbox = $(“#hotstock_checkbox”).is(“:checked”);

const isCheckboxChecked = checkbox;

if (isNameValid && isEmailValid && isPhoneValid && isCheckboxChecked && otpVerified) {
$(document).find(“#signup_form button[type=’submit’]”).prop(“disabled”, false);
}else{
$(document).find(“#signup_form button[type=’submit’]”).prop(“disabled”, true);
}
}

$(“#signup_form input”).on(“change”, function () {
setTimeout(() => toggleSendOtpButton(), 0);
});

$(“#lead_name”).on(‘input’, function() {
this.value = this.value.replace(/s{2,}/g, ‘ ‘);
this.value = this.value.replace(/[.]/g, ”);
$(this).valid();
toggleSendOtpButton();
});

$(“#lead_email”).on(‘input’, function() {
this.value = this.value.replace(/s/g, ”);
});

if(enableOTPJS){
$(“#signup_form input, #signup_form select”).on(“change”, function () {
setTimeout(() => toggleReadNowButton(), 0);
});
}

$(“#signup_form”).validate({
errorPlacement: function(error, element) {
//element.addClass(‘is-invalid’);

//$(element).siblings(‘.error’).remove();

//if ($(“.is-invalid”).length === 1) {
// error.appendTo(element.parent());
//}

if (element.attr(“name”) == “lead_name”)
error.appendTo(“#errordivname”);
else if (element.attr(“name”) == “lead_email”)
error.appendTo(“#errordivemail”);
else if (element.attr(“name”) == “lead_phone”)
error.appendTo(“#errordivmobile”);
else if (element.attr(“name”) == “hotstock_checkbox”)
error.appendTo(“#errordivcheckbox”);
else if (element.attr(“name”) == “lead_otp”)
error.appendTo(“#errordivotp”);
},

success: function(label, element) {
$(element).removeClass(‘is-invalid’);
label.remove();
},
rules: {
lead_name: {
required: true,
minlength: 2,
maxlength:50,
validName:true
},
lead_phone: {
intlTelNumber: true,
required: true,
number: true,
// validatePhone: true,
maxlength:12
},
lead_email: {
required: true,
email: true,
emailPattern: true
},
hotstock_checkbox: {
required: true,
},
lead_otp: {
required: function() {
// var selectedCountry = iti.getSelectedCountryData();
// return selectedCountry.iso2 === ‘gb’;
var selectedCountry = iti.getSelectedCountryData();
return selectedCountry.iso2 === ‘gb’ || selectedCountry.iso2 === ‘au’ || selectedCountry.iso2 === ‘ca’ || selectedCountry.iso2 === ‘us’;
},
minlength: 6,
maxlength: 6,
digits: true
},
},

onkeyup: function(element) {
this.element(element);
setTimeout(() => toggleSendOtpButton(), 0);
},
onfocusout: function(element) {
this.element(element);
setTimeout(() => toggleSendOtpButton(), 0);
},

messages: {
lead_name: {
required: ‘Please enter valid name.’,
minlength: ‘Name must be at least 4 characters long.’
},
lead_email: {
required: ‘Please enter a valid email address’,
email: ‘Please enter a valid email address (e.g., abc@gmail.com)’,
emailPattern: ‘Please enter a valid email address (e.g., abc@gmail.com)’
},
lead_phone: {
required: ‘Please enter valid mobile number.’
},
hotstock_checkbox: {
required: ‘Please read our Terms and Conditions.’
},
lead_otp: {
required: ‘Valid OTP is required that you’ve received on your number.’
},
},

submitHandler: function(form) {
event.preventDefault();
var navigate_url = $(“.navigate_url”).val();
$(“#signup_form”).find(‘:submit’).html(‘ Loading…’).prop(‘disabled’,true);
// var countryCode = $(“#signup_form”).find(‘div.iti__selected-dial-code’).html()
var selectedCountryData = iti.getSelectedCountryData();
var countryCode = selectedCountryData.iso2;
var countryCode2 = selectedCountryData.dialCode;
$(”).attr({
type: ‘hidden’,
id: ‘countryCode’,
name: ‘countryCode’,
value: countryCode2
}).appendTo(‘#signup_form’);
$(”).attr({
type: ‘hidden’,
id: ‘countryCodeISO’,
name: ‘countryCodeISO’,
value: countryCode
}).appendTo(‘#signup_form’);

var url = “https://kalkinemedia.com/a/checkPhoneNumber”;

url =`${url}/${countryCode2+$(document).find(“#lead_phone”).val()}`

if (enableOTPJS && !otpVerified) {
toast_msg(“OTP Verification required”, ‘error’);
$(“#signup_form”).find(‘:submit’).html(‘Read Now’).prop(‘disabled’, false);
return
}

$.get(url, function(response) {
if (response.status) {

$(”).attr({
type: ‘hidden’,
id: ‘telesignScore’,
name: ‘telesignScore’,
value: response.data.telesign_info ?? “NA”
}).appendTo(‘#signup_form’);

$(”).attr({
type: ‘hidden’,
id: ‘addrScore’,
name: ‘addrScore’,
value: ($(document).find(“#ref_id”).val() !== ” && otpVerified) ? ‘true’: ‘false’
}).appendTo(‘#signup_form’);

// if (response.otp_required && $(document).find(“.otp-form-group”).hasClass(“d-none”)) {
//$(document).find(“.otp-form-group”).removeClass(“d-none”)
// } else {
// $(document).find(“.otp-form-group”).addClass(“d-none”)
// }

$.ajax({
headers: {
‘X-CSRF-TOKEN’: ‘jWzLcq7G6rLJFs8CkQXalU2RktZaisJITmmwKk7q’
},
type: “POST”,
url: “https://kalkinemedia.com/user/content_block/lead”,
data: $(form).serialize(),
dataType: ‘json’,
success: function(result) {
if (result.status == 1) {
window.location.href = result.redirect_url;
showMessage(“success”, result.message)
} else {
showMessage(“error”, result.message)
$(“#signup_form”).find(‘:submit’).html(
‘Updating’).prop(‘disabled’, false);
}
}
});

}
}).fail(function(jqXHR, textStatus, errorThrown) {
// Handle errors
// console.error(‘Error:’, textStatus, errorThrown);
});

return false;
}
});
});